Skip to main content

Day: March 4, 2021

ReWalk Robotics to Present at the H.C. WAINWRIGHT Global Life Sciences Virtual Conference

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, March 04, 2021 (GLOBE NEWSWIRE) — ReWalk Robotics Ltd. (“ReWalk” or the “Company”) (Nasdaq: RWLK) today announced that Larry Jasinski, Chief Executive Officer and Ori Gon, Chief Financial Officer will present at H.C.WAINWRIGHT global life science conference held on March 9 – 10, 2021.A company presentation will be available to view on-demand as of 7:00 AM EST, Tuesday, March 9, 2021 and throughout the conference in the following link https://journey.ct.events/view/6a0c05fb-238a-4665-8be3-13f91fdab5a4.About ReWalk Robotics Ltd.ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke.  ReWalk’s mission is to fundamentally change the quality of life for individuals...

Continue reading

Constellation Brands to Report Full Fiscal Year and Fourth Quarter 2021 Financial Results; Host Conference Call April 8, 2021

VICTOR, N.Y., March 04, 2021 (GLOBE NEWSWIRE) — Constellation Brands, Inc. (NYSE: STZ and STZ.B), a leading beverage alcohol company, announced today it will report financial results for its full fiscal year and fourth quarter ended February 28, 2021, on Thursday, April 8, 2021, before the open of the U.S. markets. A conference call to discuss the financial results and outlook will be hosted by President and Chief Executive Officer Bill Newlands and Executive Vice President and Chief Financial Officer Garth Hankinson at 11:30 a.m. EDT, April 8, 2021.The conference call can be accessed by dialing +1-877-673-1771 and entering conference identification number 4192805, beginning at 11:20 a.m. EDT. A live, listen-only webcast of the conference call will be available on the company’s website, www.cbrands.com, under the Investors/Events...

Continue reading

MICT Announces Closing of $54 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

MONTVALE, N.J., March 04, 2021 (GLOBE NEWSWIRE) — MICT, Inc. (Nasdaq: MICT) (the “Company”), today announced that it closed its previously announced registered direct offering of (i) 19,285,715 shares of common stock and (ii) 19,285,715 warrants to purchase 19,285,715 shares of common stock at a combined purchase price of $2.80. The gross proceeds to MICT from this offering are approximately $54,000,000, before deducting placement agent fees and other estimated offering expenses. The warrants are exercisable immediately, have an exercise price of $2.80 per share and expire five years from the date of issuance.A.G.P./Alliance Global Partners acted as sole placement agent for the offering.This offering was made pursuant to an effective shelf registration statement on Form S-3 (No. 333-248602) previously filed with the U.S. Securities...

Continue reading

Quanex Building Products Announces First Quarter 2021 Results and Increases Full Year 2021 Guidance

Solid Growth and Significant Margin Expansion Realized Across All Operating SegmentsBalance Sheet Remains StrongPositive Outlook IntactHOUSTON, March 04, 2021 (GLOBE NEWSWIRE) — Quanex Building Products Corporation (NYSE:NX) (“Quanex” or the “Company”) today announced its results for the three months ended January 31, 2021.The Company reported the following selected financial results:George Wilson, President and Chief Executive Officer, stated, “We posted another very strong quarter as demand for our products remained high throughout the first quarter of 2021. In fact, we realized solid growth and significant margin expansion in each of our operating segments. On a consolidated basis, net sales increased by 17.1% and Adjusted EBITDA margin improved by approximately 260 basis points year-over-year as compared to the first quarter...

Continue reading

CooperCompanies Announces First Quarter 2021 Results

SAN RAMON, Calif., March 04, 2021 (GLOBE NEWSWIRE) — CooperCompanies (NYSE: COO) today announced financial results for its fiscal first quarter ended January 31, 2021.Revenue increased 5% year-over-year to $680.5 million. CooperVision (CVI) revenue up 4% to $507.0 million, and CooperSurgical (CSI) revenue up 8% to $173.5 million.GAAP diluted earnings per share $42.31, up $40.49 from last year’s first quarter.Non-GAAP diluted earnings per share $3.17, up $0.48 or 18% from last year’s first quarter. See “Reconciliation of Selected GAAP Results to Non-GAAP Results” below.Commenting on the results, Al White, Cooper’s President and CEO said, “We’ve started the year on a positive note, and we’re excited about our momentum. Both our businesses performed well, delivering strong operational...

Continue reading

Costco Wholesale Corporation Reports Second Quarter and Year-to-Date Operating Results for Fiscal 2021 and February Sales Results

ISSAQUAH, Wash., March 04, 2021 (GLOBE NEWSWIRE) — Costco Wholesale Corporation (“Costco” or the “Company”) (Nasdaq: COST) today announced its operating results for the second quarter (twelve weeks) and the first 24 weeks of fiscal 2021, ended February 14, 2021.Net sales for the quarter increased 14.7 percent, to $43.89 billion, from $38.26 billion last year. Net sales for the first 24 weeks increased 15.8 percent, to $86.23 billion, from $74.49 billion last year.Comparable sales for the second quarter fiscal 2021 were as follows:Net income for the quarter was $951 million, or $2.14 per diluted share, which includes $246 million pretax, or $0.41 per diluted share, in costs incurred primarily from COVID-19 premium wages. Last year’s second quarter net income was $931 million, or $2.10 per diluted share. Net income for the first 24...

Continue reading

INmune Bio, Inc. Announces Fourth Quarter and Full Year 2020 Results and Provides Business Update

LA JOLLA, Calif., March 04, 2021 (GLOBE NEWSWIRE) — INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today reported its financial results for the year ended December 31, 2020 and provided a business update.“A key highlight since our last quarterly update is the updated interim data announced from our ongoing Phase 1b study evaluating XPro1595 in Alzheimer’s disease in January,” stated RJ Tesi, M.D., chief executive officer of INmune Bio. “These data demonstrate that XPro1595 decreases neuroinflammation using multiple biomarkers of inflammation in patients with Alzheimer’s disease. We also gained insight into the consequences of decreasing neuroinflammation in these patients for extended period of...

Continue reading

Crawford & Company Reports 2020 Fourth Quarter and Full Year Results

ATLANTA, March 04, 2021 (GLOBE NEWSWIRE) — Crawford & Company® (NYSE: CRD-A and CRD-B), the world’s largest publicly listed independent provider of claims management and outsourcing solutions to carriers, brokers and corporations, today announced its financial results for the fourth quarter ended December 31, 2020.The Company’s two classes of stock are substantially identical, except with respect to voting rights and the Company’s ability to pay greater cash dividends on the non-voting Class A Common Stock (CRD-A) than on the voting Class B Common Stock (CRD-B), subject to certain limitations. In addition, with respect to mergers or similar transactions, holders of CRD-A must receive the same type and amount of consideration as holders of CRD-B, unless different consideration is approved by the holders of 75% of CRD-A, voting...

Continue reading

Tribune Publishing Reports Fourth Quarter and Full-Year 2020 Results

Digital content revenues increased 57.0% year-over-yearNet increase in cash of $36.7 millionCHICAGO, March 04, 2021 (GLOBE NEWSWIRE) — Tribune Publishing Company (NASDAQ:TPCO) today announced financial results for the fourth quarter and full year ended December 27, 2020. Unless otherwise noted, amounts and disclosures throughout this earnings release relate to continuing operations and exclude BestReviews LLC.2020 Full Year Highlights:Net increase in cash of $36.7 million compared to December 29, 2019Reduced lease obligations by $51.1 million, pension obligations by $3.5 million and a capital lease (classified as debt) by $6.9 millionDigital-only subscribers increased 30.5% to 436 thousand at the end of the fourth quarter 2020, up from 334 thousand at the end of the fourth quarter 2019Digital content revenues increased $16.5 million...

Continue reading

NXP Semiconductors Announces a 50 percent Increase in the Quarterly Dividend and Adoption of 2021 Share Repurchase Program

EINDHOVEN, The Netherlands, March 04, 2021 (GLOBE NEWSWIRE) — As part of its ongoing capital return program, NXP Semiconductors N.V. (NASDAQ: NXPI) today announced that its board of directors has approved the payment of an interim dividend and the adoption of a new 2021 share repurchase authorization. The actions are based on the significant strength of the NXP capital structure, and the board’s confidence in the company’s ability to drive long-term growth and strong cash flow.The board of directors has approved the payment of an interim dividend of $0.5625 per ordinary share for the first quarter of 2021. The interim dividend reflects an increase of 50 percent from the prior quarterly dividend and will be paid in cash on April 5, 2021 to shareholders of record as of March 15, 2021.Additionally, consistent with NXP’s historic policy...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.